Anti-carcinogenic	anti-carcinogenic	O	O	O	O
action	action	O	O	O	O
of	of	O	O	O	O
phenobarbital	phenobarbital	CHEMICALS	O	OTHERS	I
given	given	O	O	O	O
simultaneously	simultaneously	O	O	O	O
with	with	O	O	O	O
diethylnitrosamine	diethylnitrosamine	O	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
rat	rat	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
present	present	O	O	O	O
work	work	O	O	O	O
has	has	O	O	O	O
been	been	O	O	O	O
planned	planned	O	O	O	O
in	in	O	O	O	O
order	order	O	O	O	O
to	to	O	O	O	O
elucidate	elucidate	O	O	O	O
the	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
phenobarbital	phenobarbital	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
PB	pb	O	O	OTHERS	I
:	:	O	O	O	O
15	15	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
rat	rat	O	O	O	O
of	of	O	O	O	O
ingested	ingested	O	O	O	O
dose	dose	O	O	O	O
)	)	O	O	O	O
on	on	O	O	O	O
carcinogenesis	carcinogenesis	O	DISEASE	OTHERS	I
when	when	O	O	O	O
it	it	O	O	O	O
is	is	O	O	O	O
administered	administered	O	O	O	O
simultaneously	simultaneously	O	O	O	O
with	with	O	O	O	O
diethylnitrosamine	diethylnitrosamine	O	O	OTHERS	I
(	(	O	O	O	O
DEN	den	O	O	OTHERS	I
:	:	O	O	O	O
10	10	O	O	O	O
mg/kg/day	mg/kg/day	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Wistar	wistar	O	O	O	O
rats	rats	O	O	O	O
(	(	O	O	O	O
180	180	O	O	O	O
g	g	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
treated	treated	O	O	O	O
by	by	O	O	O	O
DEN	den	O	O	OTHERS	I
alone	alone	O	O	O	O
or	or	O	O	O	O
by	by	O	O	O	O
DEN	den	O	O	OTHERS	I
+	+	O	O	O	O
PB	pb	O	O	OTHERS	I
during	during	O	O	O	O
2	2	O	O	O	O
,	,	O	O	O	O
4	4	O	O	O	O
and	and	O	O	O	O
6	6	O	O	O	O
weeks	weeks	O	O	O	O
according	according	O	O	O	O
to	to	O	O	O	O
our	our	O	O	O	O
schedule	schedule	O	O	O	O
for	for	O	O	O	O
hepatocarcinogenesis	hepatocarcinogenesis	O	O	OTHERS	I
.	.	O	O	O	O

After	after	O	O	O	O
the	the	O	O	O	O
end	end	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
number	number	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
size	size	O	O	O	O
of	of	O	O	O	O
induced	induced	O	O	O	O
PAS	pas	O	O	OTHERS	I
positive	positive	O	O	O	O
preneoplastic	preneoplastic	O	O	OTHERS	I
foci	foci	O	O	OTHERS	I
was	was	O	O	O	O
significantly	significantly	O	O	O	O
reduced	reduced	O	O	O	O
when	when	O	O	O	O
PB	pb	O	O	OTHERS	I
was	was	O	O	O	O
given	given	O	O	O	O
simultaneously	simultaneously	O	O	O	O
with	with	O	O	O	O
DEN	den	O	O	OTHERS	I
for	for	O	O	O	O
4	4	O	O	O	O
and	and	O	O	O	O
6	6	O	O	O	O
weeks	weeks	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
mitotic	mitotic	O	O	O	O
inhibition	inhibition	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
production	production	O	O	O	O
of	of	O	O	O	O
micronuclei	micronuclei	O	O	O	O
normally	normally	O	O	O	O
observed	observed	O	O	O	O
after	after	O	O	O	O
partial	partial	O	O	O	O
hepatectomy	hepatectomy	O	O	O	O
in	in	O	O	O	O
DEN	den	O	O	OTHERS	I
treated	treated	O	O	O	O
rats	rats	O	O	O	O
were	were	O	O	O	O
also	also	O	O	O	O
significantly	significantly	O	O	O	O
decreased	decreased	O	O	O	O
in	in	O	O	O	O
DEN	den	O	O	OTHERS	I
+	+	O	O	O	O
PB	pb	O	O	OTHERS	I
treated	treated	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

When	when	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
last	last	O	O	O	O
only	only	O	O	O	O
2	2	O	O	O	O
weeks	weeks	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
PB	pb	O	O	OTHERS	I
did	did	O	O	O	O
not	not	O	O	O	O
change	change	O	O	O	O
significantly	significantly	O	O	O	O
the	the	O	O	O	O
last	last	O	O	O	O
parameters	parameters	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
DEN	den	O	O	OTHERS	I
+	+	O	O	O	O
PB	pb	O	O	OTHERS	I
treated	treated	O	O	O	O
rats	rats	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
survival	survival	O	O	O	O
was	was	O	O	O	O
prolonged	prolonged	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
tumor	tumor	O	DISEASE	OTHERS	I
incidence	incidence	O	O	O	O
decreased	decreased	O	O	O	O
as	as	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
results	results	O	O	O	O
obtained	obtained	O	O	O	O
by	by	O	O	O	O
DEN	den	O	O	OTHERS	I
alone	alone	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
concluded	concluded	O	O	O	O
that	that	O	O	O	O
PB	pb	O	O	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
promotes	promotes	O	O	O	O
carcinogenesis	carcinogenesis	O	DISEASE	OTHERS	I
when	when	O	O	O	O
administered	administered	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
DEN	den	O	O	OTHERS	I
treatment	treatment	O	O	O	O
,	,	O	O	O	O
reduces	reduces	O	O	O	O
the	the	O	O	O	O
carcinogen	carcinogen	O	O	O	O
effect	effect	O	O	O	O
when	when	O	O	O	O
given	given	O	O	O	O
simultaneously	simultaneously	O	O	O	O
with	with	O	O	O	O
DEN	den	O	O	OTHERS	I
.	.	O	O	O	O

This	this	O	O	O	O
'	'	O	O	O	O
anti-carcinogen	anti-carcinogen	O	O	O	O
'	'	O	O	O	O
effect	effect	O	O	O	O
acts	acts	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
initiation	initiation	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
promotion	promotion	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
precancerous	precancerous	O	O	OTHERS	I
lesions	lesions	O	O	OTHERS	I
.	.	O	O	O	O

Biochemical	biochemical	O	O	O	O
investigations	investigations	O	O	O	O
are	are	O	O	O	O
in	in	O	O	O	O
progress	progress	O	O	O	O
to	to	O	O	O	O
obtain	obtain	O	O	O	O
more	more	O	O	O	O
information	information	O	O	O	O
about	about	O	O	O	O
this	this	O	O	O	O
'	'	O	O	O	O
paradoxical	paradoxical	O	O	O	O
'	'	O	O	O	O
PB	pb	O	O	OTHERS	I
effect	effect	O	O	O	O
.	.	O	O	O	O

